Ocrelizumab extended dosing in Primary Progressive Multiple Sclerosis during the COVID-19 pandemic: a multicenter experience

被引：0
|
作者：
D'Amico, E. [1 ]
Avolio, C. [1 ]
Lus, G. [2 ]
Bonavita, S. [3 ]
Ferraro, D. [4 ]
Callari, G. [5 ]
Barone, S. [6 ]
Patti, F. [7 ]
Granella, F. [8 ]
Zanghi, A. [9 ]
机构：
[1] Univ Foggia, Foggia, Italy
[2] Univ Campania Luigi Vanvitelli, Naples, Italy
[3] Univ Naples Federico II, Naples, Italy
[4] Univ Modena, Modena, Italy
[5] Irccs Cefalu, Cefalu, Italy
[6] Univ Catanzaro, Catanzaro, Italy
[7] Uni Catania, Catania, Italy
[8] Univ Parma, Parma, Italy
[9] Sant Elia Hosp, Caltanissetta, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2022年 / 28卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1246
引用
下载
收藏
页码：1007 / 1008
页数：2
相关论文
共 50 条
  • [21] Treatment of multiple sclerosis during COVID-19 pandemic
    Brola, Waldemar
    Kosno, Krystian
    Mitrosz, Agnieszka
    AKTUALNOSCI NEUROLOGICZNE, 2021, 21 (03): : 131 - 136
  • [22] Multiple Sclerosis Management During the COVID-19 Pandemic
    Hollen, Chris
    Bernard, Jacqueline
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2022, 22 (08) : 537 - 543
  • [23] Multiple sclerosis management during the COVID-19 pandemic
    Moss, Brandon P.
    Mahajan, Kedar R.
    Bermel, Robert A.
    Hellisz, Kelsey
    Hua, Le H.
    Hudec, Timothy
    Husak, Scott
    McGinley, Marisa P.
    Ontaneda, Daniel
    Wang, Zhini
    Weber, Malory
    Tagliani, Paula
    Cardenas-Robledo, Simon
    Zabalza, Ana
    Arrambide, Georgina
    Carbonell-Mirabent, Pere
    Rodriguez-Barranco, Marta
    Sastre-Garriga, Jaume
    Tintore, Mar
    Montalban, Xavier
    Douglas, Morgan
    Ogbuokiri, Esther
    Aravidis, Berna
    Cohen, Jeffrey A.
    Mowry, Ellen M.
    Fitzgerald, Kathryn C.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (10) : 1163 - 1171
  • [24] The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis
    Nancy D. Chiaravalloti
    Maria Pia Amato
    Giampaolo Brichetto
    Jeremy Chataway
    Ulrik Dalgas
    John DeLuca
    Cecilia Meza
    Nancy B. Moore
    Peter Feys
    Massimo Filippi
    Jennifer Freeman
    Matilde Inglese
    Rob Motl
    Maria Assunta Rocca
    Brian M. Sandroff
    Amber Salter
    Gary Cutter
    Anthony Feinstein
    Journal of Neurology, 2021, 268 : 1598 - 1607
  • [25] The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis
    Chiaravalloti, Nancy D.
    Amato, Maria Pia
    Brichetto, Giampaolo
    Chataway, Jeremy
    Dalgas, Ulrik
    DeLuca, John
    Meza, Cecilia
    Moore, Nancy B.
    Feys, Peter
    Filippi, Massimo
    Freeman, Jennifer
    Inglese, Matilde
    Motl, Rob
    Rocca, Maria Assunta
    Sandroff, Brian M.
    Salter, Amber
    Cutter, Gary
    Feinstein, Anthony
    JOURNAL OF NEUROLOGY, 2021, 268 (05) : 1598 - 1607
  • [26] The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis
    Chiaravalloti, N.
    Amato, M. P.
    Brichetto, G.
    Chataway, J.
    Dalgas, U.
    Deluca, J.
    Meza, C.
    Moore, N.
    Feys, P.
    Filippi, M.
    Freeman, J.
    Inglese, M.
    Motl, R.
    Rocca, M. A.
    Sandroff, B.
    Salter, A.
    Cutter, G.
    Feinstein, A.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 71 - 72
  • [27] Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis
    Mildiner, Sorcha
    Malnick, Stephen
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (17): : 1692 - 1693
  • [28] Beyond ocrelizumab in primary progressive multiple sclerosis
    Thomas Williams
    Jeremy Chataway
    Nature Reviews Neurology, 2022, 18 : 641 - 642
  • [29] Beyond ocrelizumab in primary progressive multiple sclerosis
    Williams, Thomas
    Chataway, Jeremy
    NATURE REVIEWS NEUROLOGY, 2022, 18 (11) : 641 - 642
  • [30] Clinical impact of Ocrelizumab extended interval dosing during the COVID-19 pandemic and associations with CD19+ B-cell repopulation
    Sahi, Nitin Kumar
    Abidi, Syed Muhammad Ali
    Salim, Omar
    Abraham, Roby
    Kalra, Seema
    Al-Araji, Adnan
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 56
12345